Weiss Multi-Strategy Advisers’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-153,509
Closed -$8.18M 202
2023
Q4
$8.18M Buy
153,509
+85,374
+125% +$4.16M 0.2% 131
2023
Q3
$3.38M Buy
68,135
+7,268
+12% +$406K 0.08% 303
2023
Q2
$3.62M Buy
60,867
+43,167
+244% +$2.46M 0.07% 358
2023
Q1
$1M Buy
+17,700
New +$1.13M 0.02% 512
2014
Q2
Sell
-8,520
Closed -$227K 805
2014
Q1
$227K Sell
8,520
-2,990
-26% -$71K ﹤0.01% 885
2013
Q4
$232K Sell
11,510
-4,320
-27% -$80.2K 0.01% 868
2013
Q3
$276K Buy
+15,830
New +$274K 0.01% 673

Other funds holding GMED

Weiss Multi-Strategy Advisers's GMED Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Globus Medical (GMED) in Q1 2024, closing a stake of 153,509 shares — an estimated $8.18M sold.

Weiss Multi-Strategy Advisers first reported a position in GMED in Q3 2013 and held it in 7 quarters. The position peaked at $8.18M in Q4 2023. 439 funds tracked by Wall St. Rank hold GMED as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Globus Medical position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 153,509 Globus Medical shares in Q1 2024, an estimated $8.18M.
  • Weiss Multi-Strategy Advisers first reported a position in Globus Medical in Q3 2013 and held it in 7 quarters.
  • Weiss Multi-Strategy Advisers's Globus Medical position peaked at $8.18M in Q4 2023.
  • 439 funds tracked by Wall St. Rank held Globus Medical as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.